Form 4: Vivek Ramaswamy Sells Roivant Sciences Shares

Vivek Ramaswamy, a director and 10% owner of Roivant Sciences Ltd., sold a significant number of common shares over two days in May 2025.

Summary

• Vivek Ramaswamy, a director and 10% owner of Roivant Sciences Ltd., reported the sale of Roivant Sciences Ltd. common shares.
• On May 6, 2025, Ramaswamy sold 273,959 shares at a weighted average price of $11.47, with prices ranging from $11.45 to $11.52.
• On May 7, 2025, Ramaswamy sold 625,000 shares at a weighted average price of $11.18, with prices ranging from $11.10 to $11.26.
• Following these transactions, Ramaswamy directly owns 39,174,611 common shares.
• Ramaswamy also indirectly owns 13,357,857 shares through spousal ownership.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. While the document only reports share sales, large sales by significant shareholders can sometimes be interpreted negatively by the market.

Industry Context

Sales of shares by significant shareholders are common and can be for a variety of reasons, including portfolio diversification or personal financial planning. It is important to consider the overall context of the company's performance and industry trends when interpreting such transactions.

Stakeholder Impact

• Shareholders may react to the news of share sales by a major shareholder.
• The market price of Roivant Sciences shares could be affected by these transactions.

Key Dates

Keywords

Roivant Sciences, Vivek Ramaswamy, share sale, Form 4, beneficial ownership, ROIV